Document is current
Any future updates will be listed below
-
Authors
Ngo, Clemence
Pierini-Malosse, Camille
Rahmani, Khalissa
Valente, Michael
Collinet, Nils
Bessou, Gilles
Guerry, Capucine
Fabregue, Manon
Mathieu, Solene
Sharkaoui, Sarah
Mazzoli, Sophie https://orcid.org/0009-0005-6516-2064
Sansoni, Amandine
Fiore, Frederic https://orcid.org/0000-0001-7955-6594
Laprie, Caroline
Alexopoulou, Lena https://orcid.org/0000-0003-4619-697X
Gaya, Mauro
Gregoire, Claude
Broggi, Achille
Wurbel, Sarah
Rua, Réjane
Haidar, Narjess
Milpied, Pierre https://orcid.org/0000-0003-1873-5358
Escalière, Bertrand
Vu Manh, Thien Phong
Fallet, Mathieu
Chasson, Lionel
Tran, Hien
Baranek, Thomas
Le Bert, Marc https://orcid.org/0000-0002-5945-3800
Malissen, Bernard https://orcid.org/0000-0003-1340-9342
Zarubica, Ana https://orcid.org/0000-0001-5488-4137
Dalod, Marc https://orcid.org/0000-0002-6436-7966
Tomasello, Elena https://orcid.org/0000-0002-6839-5219
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche
- License Information
-
More Information
Article History
Received: 22 May 2024
Accepted: 26 August 2025
First Online: 29 September 2025
Competing interests
: F.F., B.M., A.Z., M.D. and E.T. are inventors on a patent application filed on the targeting of pDCs to treat certain respiratory viral infections. The other authors declare no competing interests.
